MAPRx letter to the Senate Committee on Finance regarding its drug pricing legislative package
Published: Jul 25, 2019
Tagged in: Access to Affordable Medicines, Federal Drug Pricing Legislation in the 116th Congress
For decades, NORD has pursued federal and state policies that will change the lives of Americans impacted by rare diseases for the better. NORD’s work can be viewed below. This page is updated daily to provide timely information. Please contact us if you have questions or need additional information.
MAPRx letter to the Senate Committee on Finance regarding its drug pricing legislative package
Published: Jul 25, 2019
Tagged in: Access to Affordable Medicines, Federal Drug Pricing Legislation in the 116th Congress
NORD letter to the Senate Committee on Finance regarding its drug pricing legislative package
Published: Jul 24, 2019
Tagged in: Access to Affordable Medicines, Federal Drug Pricing Legislation in the 116th Congress
NORD letter to the Senate Committee on Health, Education, Labor and Pensions (HELP) on the Lower Health Care Costs Act of 2019 (S. 1895)
Published: Jun 25, 2019
Tagged in: Access to Affordable Medicines, Federal Drug Pricing Legislation in the 116th Congress
NORD comments on the Senate Health, Education, Labor, and Pensions (HELP) Committee’s draft legislation, the Lower Health Care Costs Act of 2019
Published: Jun 5, 2019
Tagged in: Access to Affordable Medicines, Federal Drug Pricing Legislation in the 116th Congress
Coalition letter to Congress in opposition to draft legislation that would amend Section 101 of the Patent Act
Published: Jun 3, 2019
Tagged in: Access to Affordable Medicines, Federal Drug Pricing Legislation in the 116th Congress
NORD letter to Congress in support of provisions in the new H.R.987, legislation that aims to lower drug costs and improve the Affordable Care Act (ACA)
Published: May 15, 2019
Tagged in: Access to Affordable Medicines, Federal Drug Pricing Legislation in the 116th Congress